12 Korean drugmakers at risk of losing “innovative drug firm’ status

Published: 2013-01-25 06:59:00

Updated: 2013-01-25 06:59:00

The government selected 43 companies last June as “innovative pharmaceutical firms.” Those in the category receive various benefits, including priority to participate in state-run research and development projects, tax redemption, as well as financial support for building research labs.

Howeve...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK